Tubular Epithelia-Specific Deletion of MCP-1 Does Not Afford Protection Against Adriamycin-Induced Kidney Injury
Open Access
- 6 March 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (5) , 2432
Abstract
The increasing global burden of chronic kidney disease (CKD) magnifies an urgent need to find treatable targets. Monocyte chemoattractant protein-1 (MCP-1/CCL2) is a chemokine secreted by kidney tubular epithelia in response to a variety of stimuli. To better understand the effects of tubular MCP-1 in response to kidney injury, we generated tubular epithelia-specific MCP-1 knockout mice (KO; Pax8-Mcp-1fl/fl). We then exposed these mice and their control littermates to Adriamycin (Adr; 18 mg/kg, IV bolus). Thirty-two days after Adr injection, Mcp-1 transcript and protein levels were suppressed in the KO mice compared to their wild-type (WT) littermates. The KO mice exhibited no effect on survival, change in body weight, albuminuria, kidney function, glomerular or tubular injury, or tubulointerstitial fibrosis compared to WT. Overall, the results suggest that tubule-secreted MCP-1 is not necessary for progression of Adr-induced injury. These findings contribute to our understanding of the role of MCP-1 in kidney injury.Keywords
Funding Information
- National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (K01DK124357)
- Department of Veterans Affairs Merit Award (I01BX005680)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK131991)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK064005)
- UMRAA Department of Defense Award (W81XWH-22-10845)
- National Institutes of Health (1S10OD028596)
- National Institutes of Health (1S10OD028596)
- National Institutes of Health (P30DK079307)
- National Institutes of Health (U54DK137329)
This publication has 57 references indexed in Scilit:
- Monocyte chemoattractant protein‐1 predicts the development of diabetic nephropathyDiabetes/Metabolism Research and Reviews, 2021
- Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in miceKidney International, 2017
- Pathophysiology of Acute Kidney InjuryComprehensive Physiology, 2012
- The MCP-1/CCR2 axis in podocytes is involved in apoptosis induced by diabetic conditionsApoptosis, 2011
- Bone Marrow Mesenchymal Stem and Progenitor Cells Induce Monocyte Emigration in Response to Circulating Toll-like Receptor LigandsImmunity, 2011
- Aberrant cytokines/chemokines production correlate with proteinuria in patients with overt diabetic nephropathyClinica Chimica Acta, 2010
- Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathyCytokine, 2009
- Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cellsDiabetologia, 2007
- Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathyBiochemical and Biophysical Research Communications, 2007
- Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db miceDiabetologia, 2006